Article
An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.
Gastroenterology - 1 Mar 2010
Kucherlapati Melanie H, Lee Kyeryoung, Nguyen Andrew A, Clark Alan B, Hou Harry, Rosulek Andrew, Li Hua, Yang Kan, Fan Kunhua, Lipkin Martin, Bronson Roderick T, Jelicks Linda, Kunkel Thomas A, Kucherlapati Raju, Edelmann Winfried
Abstract excerpt
BACKGROUND & AIMS: Mutations in the DNA mismatch repair (MMR) gene MSH2 cause Lynch syndromes I and II and sporadic colorectal cancers. Msh2(null) mice predominantly develop lymphoma and do not accurately recapitulate the colorectal cancer phenotype. METHODS: We generated and examined mice with a conditional Msh2 disruption (Msh2(LoxP)), permitting tissue-specific gene inactivation. ECMsh2(LoxP/LoxP) mice carried...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
